The total return over the past 12 months is -50.23% vs. +16.94% for the S&P 500. So far it's up +42.05% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (50.23%) | (22.68%) | (42.54%) | N/A | N/A | N/A |
| Total Return CAGR | (50.23%) | (22.68%) | (42.54%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Vor Biopharma Inc. (VOR)
| Year | Start price | End price | VOR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $13.08 | $18.58 | +42.05% | +14.51% | +27.54% |
| 2025 | $22.20 | $13.08 | (41.08%) | +17.72% | (58.80%) |
| 2024 | $45.00 | $22.20 | (50.67%) | +24.89% | (75.56%) |
| 2023 | $133.00 | $45.00 | (66.17%) | +26.19% | (92.36%) |
| 2022 | $232.40 | $133.00 | (42.77%) | (18.17%) | (24.60%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
